Form 4: Director Sells COCO Shares Under 10b5-1 Plan

Vita Coco Company Director Kenneth Sadowsky sold 3,900 shares of common stock for a weighted average price of $51.621 under a pre-arranged 10b5-1 trading plan.

Summary

• Kenneth Sadowsky, a Director of Vita Coco Company, Inc. (COCO), reported a sale of common stock.
• The transaction involved the disposition of 3,900 shares of common stock on December 17, 2025.
• The shares were sold at a weighted average price of $51.621, with individual sales ranging from $51.24 to $52.23.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction.
• Following this transaction, Sadowsky beneficially owns 612,166 shares of common stock directly.
• Sadowsky also holds 27,300 fully vested and exercisable non-qualified stock options with an exercise price of $10.178, expiring on January 2, 2030.

Sentiment

Score: 5

Explanation: The filing reports a routine insider sale executed under a pre-arranged 10b5-1 plan, which is generally considered neutral. While a director selling shares can sometimes be viewed negatively, the pre-planned nature and the director's continued substantial holdings mitigate significant negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than an immediate reaction to new information.
• The director retains a significant beneficial ownership of 612,166 shares of common stock, plus 27,300 stock options, demonstrating continued alignment with shareholder interests.

Negatives

• A director selling shares, even if pre-planned, could be perceived negatively by some investors as it reduces their direct equity stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the director's sale as a slight negative signal, though mitigated by the 10b5-1 plan and continued significant ownership.

Key Dates

Recommendation

This Form 4 reports a routine insider sale by a director under a pre-arranged 10b5-1 plan. Such transactions are typically not indicative of a change in the company's fundamental outlook or performance. The director retains a substantial equity stake, suggesting continued alignment with shareholder interests. Therefore, the filing itself does not provide a basis for a change in investment recommendation, warranting a 'hold' position based solely on this information.

Keywords

Vita Coco Company, COCO, Kenneth Sadowsky, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director Transaction, Equity Disclosure